CD4 and B-cell non-Hodgkin lymphoma: Using a mouse B-cell lymphoma model, we provided clear evidence that PD1high CD4+ T cells constituted a fraction of tumor antigen-experienced cells and were associated with downregulation of IL7 receptor and elevated level of apoptosis [64].